Podcast Episodes
Back to SearchSpecialist Spotlight on Diversity, Equity, and Inclusion in Retinal Medicine
Episode 278
In this specialist spotilight, Drs. Yiu and Emami-Naeini share their insights into Diversity, Equity and Inclusion in retinal medicine including rese…
3 years, 2 months ago
Specialist Spotlight on Myelofibrosis: JAK inhibitor Drug Choice and Dosing Strategy
Episode 277
In this specialist spotlight, Drs. Kuykendall and Mascarenhas share their insights into JAK inhibitor drug choice in patients with myelofibrosis.
3 years, 2 months ago
Specialist Spotlight on Myelofibrosis: Approach to Patients With Myelofibrosis and Anemia
Episode 276
Drs. Mascarenhas and Kuykendall share their insights into the treatment of patients with myelofibrosis and anemia, in another segment of specialist s…
3 years, 2 months ago
Antibiotic exposure may affect COVID-19 severity
Episode 275
Is repeated antibiotic exposure associated with COVID-19 severity? Find out about this and more in today's PV Roundup podcast.
3 years, 2 months ago
FDA approves first nonprescription oral contraceptive
Episode 274
What are the details on the first nonpresciption contraceptive pill? Find out about this and more in today's PV Roundup podcast.
3 years, 2 months ago
Concomitant meds can hinder antidepressant response
Episode 273
How do concomitant meds affect antidepressant response? Find out about this and more in today's PV Roundup podcast.
3 years, 3 months ago
Novel obesity drug leads to substantial weight loss
Episode 272
Could experimental retatrutide be a game changer for patients with obesity? Find out about this and more in today's PV Roundup podcast.
3 years, 3 months ago
USPSTF recommends anxiety screening for all adults aged <65 years
Episode 271
What are the latest recommendations for anxiety screening in the primary care setting? Find out about this and more in today's PV Roundup podcast.
3 years, 3 months ago
Metformin reduces long COVID risk
Episode 270
Can a common diabetes drug reduce the risk for long COVID? Find out about this and more in today's PV Roundup podcast.
3 years, 3 months ago
Osimertinib is a game changer in NSCLC
Episode 269
How does lung cancer immunotherapy osimertinib affect 5-year survival? Find out about this and more in today's PV Roundup podcast.
3 years, 3 months ago